Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,743 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Flow-induced Shear Stress Confers Resistance to Carboplatin in an Adherent Three-Dimensional Model for Ovarian Cancer: A Role for EGFR-Targeted Photoimmunotherapy Informed by Physical Stress.
Nath S, Pigula M, Khan AP, Hanna W, Ruhi MK, Dehkordy FM, Pushpavanam K, Rege K, Moore K, Tsujita Y, Conrad C, Inci F, Carmen MGD, Franco W, Celli JP, Demirci U, Hasan T, Huang HC, Rizvi I. Nath S, et al. Among authors: moore k. J Clin Med. 2020 Mar 28;9(4):924. doi: 10.3390/jcm9040924. J Clin Med. 2020. PMID: 32231055 Free PMC article.
Photodynamic Therapy in a 3D Model of Ovarian Cancer.
Nath S, Moore K. Nath S, et al. Among authors: moore k. Bio Protoc. 2019 Aug 5;9(15):e3314. doi: 10.21769/BioProtoc.3314. eCollection 2019 Aug 5. Bio Protoc. 2019. PMID: 33654823 Free PMC article.
Mechanical Modulation of Ovarian Cancer Tumor Nodules Under Flow.
Conrad C, Moore K, Polacheck W, Rizvi I, Scarcelli G. Conrad C, et al. Among authors: moore k. IEEE Trans Biomed Eng. 2022 Jan;69(1):294-301. doi: 10.1109/TBME.2021.3092641. Epub 2021 Dec 23. IEEE Trans Biomed Eng. 2022. PMID: 34170820 Free PMC article.
Exosomes in diagnostic and therapeutic applications of ovarian cancer.
Bhavsar D, Raguraman R, Kim D, Ren X, Munshi A, Moore K, Sikavitsas V, Ramesh R. Bhavsar D, et al. Among authors: moore k. J Ovarian Res. 2024 May 25;17(1):113. doi: 10.1186/s13048-024-01417-0. J Ovarian Res. 2024. PMID: 38796525 Free PMC article. Review.
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study.
Landen CN, Buckanovich RJ, Sill MW, Mannel RS, Walker JL, DiSilvestro PA, Mathews CA, Mutch DG, Hernandez ML, Martin LP, Bishop E, Gill SE, Gordinier ME, Burger RA, Aghajanian C, Liu JF, Moore KN, Bookman MA. Landen CN, et al. Among authors: moore kn. J Clin Oncol. 2024 May 22:JCO2302076. doi: 10.1200/JCO.23.02076. Online ahead of print. J Clin Oncol. 2024. PMID: 38776484
4,743 results